U.S. Dialysis Market Size

U.S. Dialysis Market size was valued at around USD 28.8 billion in 2023 and is expected to exhibit growth at a CAGR of 5.5% from 2024 to 2032. High market growth can be attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes among other contributing factors.

The growing prevalence of ESRD is a major driver of expansion in the U.S. dialysis market. ESRD, the final stage of chronic kidney disease (CKD), requires either regular dialysis or a kidney transplant for survival, leading to a heightened demand for dialysis services and equipment. This increase in ESRD cases is largely attributed to the rising incidence of chronic conditions such as diabetes and hypertension, which are primary contributors to kidney damage. Additionally, the aging U.S. population, which experiences a natural decline in kidney function with age, further accelerates the demand for dialysis services among older adults.

For instance, according to the U.S. Renal Data System (USRDS) report 2020, there were approximately 808,000 people in the U.S. living with ESRD, with nearly 70% undergoing dialysis treatment. Additionally, the CDC reports that diabetes and hypertension are responsible for 38% and 26% of new ESRD cases, respectively. This rising prevalence of ESRD drives the expansion of the market, as it aims to address the growing needs of this increasing patient population.

Dialysis is a medical procedure that artificially performs the functions of the kidneys by removing waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to do so effectively due to kidney failure or chronic kidney disease. Dialysis helps maintain a balance of fluids, electrolytes, and waste in the body, crucial for patients with severe kidney dysfunction.